Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial

详细信息	查看全文 | 推荐本文 |

• 作者：Apichat Sangchan ; MD¹ ; ⁴ ; ; Worrarat Kongkasame ; MD² ; Ake Pugkhem ; MD³ ; ⁴ ; Kriangsak Jenwitheesuk ; MD³ ; ⁴ ; Pisaln Mairiang ; MD¹ ; ⁴
• 关键词：EBD ; endoscopic biliary drainage ; HCA ; hilar cholangiocarcinoma ; ITT ; intention-to-treat ; PS ; plastic stent ; PTBD ; percutaneous transhepatic biliary drainage ; SEMS ; self-expandable metal stent
• 刊名：Gastrointestinal Endoscopy
• 出版年：2012
• 期刊代码：130_00165107
• 类别：med
• 出版时间：July, 2012
• 卷：76
• 期：1
• 页码：93-99
• 文件大小：931 K

摘要

| Figures/TablesFigures/Tables | ReferencesReferences

Background

Endoscopic biliary stent drainage is effective in the palliative treatment of patients with hilar cholangiocarcinoma (HCA). However, no randomized controlled trial comparing the efficacy of the self-expandable metal stent (SEMS) and the plastic stent (PS) in patients with unresectable complex HCA is available.

Objective

To compare the successful drainage rates of endoscopic SEMSs and PSs.

Design

A single-center, open-label randomized controlled trial.

Setting

University hospital in KhonKaen, Thailand.

Patients

One hundred eight patients with unresectable complex, Bismuth type II-IV HCA.

Interventions

Endoscopic retrograde cholangiography with unilateral SEMS or PS insertion.

Main Outcome Measurements

Successful drainage rate.

Limitations

Diagnosis of HCA was made by clinical presentations, imaging studies, and clinical outcome during follow-up.

Results

One hundred eight patients were randomly allocated to the SEMS and PS groups. Intention-to-treat analysis revealed that the successful drainage rate in the SEMS group was higher than in the PS group (70.4%vs 46.3%, P = .011). The median survival times were 126 and 49 days, respectively, in the SEMS and PS groups. The overall survival rates of the patients in both groups were statistically different by log-rank test (P = .002).

Conclusions

Endoscopic biliary drainage with the SEMS provides better adequacy of drainage and longer survival compared with the PS in patients with unresectable complex HCA. (Clinical trial registration number: .)